Summit Securities Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.7K | Buy |
28,940
+24,713
| +585% | +$59.6K | 0.01% | 317 |
|
|
2025
Q1 | $9.34K | Buy |
+4,227
| New | +$9.34K | ﹤0.01% | 424 |
|
|
2024
Q4 | – | Sell |
-3,000
| Closed | -$25K | – | 675 |
|
|
2024
Q3 | $25K | Buy |
+3,000
| New | +$25K | 0.01% | 208 |
|
|
2024
Q1 | – | Sell |
-2,000
| Closed | -$13K | – | 578 |
|
|
2023
Q4 | $13K | Hold |
2,000
| – | – | ﹤0.01% | 311 |
|
|
2023
Q3 | $20K | Sell |
2,000
-1,000
| -33% | -$10K | ﹤0.01% | 214 |
|
|
2023
Q2 | $37K | Buy |
+3,000
| New | +$37K | ﹤0.01% | 358 |
|